🇺🇸 FDA
Pipeline program

Recombinant human growth hormone

H-49490

Phase 2 small_molecule active

Quick answer

Recombinant human growth hormone for Gulf War Syndrome is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Gulf War Syndrome
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials